Fortfahren mit
Größe auswählen
| Größe/SKU | Verfügbarkeit | Preis |
|---|---|---|
20 mg | Warenkorb auf Verfügbarkeit prüfen | € 1.800,00 |
Über diesen Artikel
grade
pharmaceutical primary standard
agency
USP
API family
rivaroxaban
manufacturer/tradename
USP
application(s)
pharmaceutical (small molecule)
pharmaceutical
pharmaceutical
format
neat
storage temp.
2-8°C
SMILES string
N3(C[C@@H](OC3=O)CN4C(=O)c5c(cccc5)C4=O)c1ccc(cc1)N2CCOCC2=O
InChI
1S/C22H19N3O6/c26-19-13-30-10-9-23(19)14-5-7-15(8-6-14)24-11-16(31-22(24)29)12-25-20(27)17-3-1-2-4-18(17)21(25)28/h1-8,16H,9-13H2/t16-/m1/s1
InChI key
KUQNYAUTIWQAKY-MRXNPFEDSA-N
General description
Application
Also, for use with USP monograph such as Rivaroxaban
Analysis Note
Other Notes
1 of 1
Dieser Artikel | |||
|---|---|---|---|
| description United States Pharmacopeia (USP) Reference Standard | description United States Pharmacopeia (USP) Reference Standard | description Pharmaceutical Analytical Impurity (PAI) | description Pharmaceutical Analytical Impurity (PAI) |
| grade pharmaceutical primary standard | grade pharmaceutical primary standard | grade pharmaceutical analytical impurity (PAI) | grade pharmaceutical analytical impurity (PAI) |
| manufacturer/tradename USP | manufacturer/tradename USP | manufacturer/tradename USP | manufacturer/tradename USP |
| format neat | format neat | format neat | format neat |
| application(s) pharmaceutical (small molecule) | application(s) pharmaceutical (small molecule) | application(s) pharmaceutical small molecule | application(s) pharmaceutical small molecule |
| agency USP | agency USP | agency USP | agency USP |
| API family rivaroxaban | API family rivaroxaban | API family rivaroxaban | API family rivaroxaban |
Hier finden Sie alle aktuellen Versionen:
Besitzen Sie dieses Produkt bereits?
In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.

